5 employees
AtG Therapeutics specializes in the development of therapeutic techniques for cancer resistance to improve the lives of cancer patients.
2022
$567K
from 3 investors over 3 rounds
AtG Therapeutics raised $567K on July 21, 2022
Investors: Blue Goose Capital, Inveniam Group and WA4STEAM